Fresenius Medical Care Adjusts China Commercial Strategy To Support Long-Term Growth And Strengthen Market Position Through More Localized Portfolio, Increased Commercialization Of Local Innovation And Focused Go-To-Market Plans
Fresenius Medical Care has operated in China for more than two decades. The market represents approximately 6-7% of the Company's Care Enablement operating segment revenues and offers long-term growth opportunities
Fresenius is changing how it does business in China to grow better there. Watch whether their new local focus helps them earn more money in that important market.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.